Perumal, N., Gopalakrishnan, P., Burkovetskaya, M., Doss, D., Dukkipati, S. S., Kanchan, R. K., & Mahapatra, S. (2025). Nuclear factor I/B: Duality in action in cancer pathophysiology. Cancer Letters, 609, 217349. https://doi.org/10.1016/j.canlet.2024.217349

Jeong, M.-S., Baek, S.-W., Yang, G.-E., Mun, J.-Y., Kim, J. A., Kim, T.-N., Nam, J.-K., Choi, Y.-H., Lee, J.-S., Chu, I.-S., & Leem, S.-H. (2025). Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Letters, 610, 217339. https://doi.org/10.1016/j.canlet.2024.217339

De Martino, M., Daviaud, C., Minns, H. E., Lazarian, A., Wacker, A., Costa, A. P., Attarwala, N., Chen, Q., Choi, S.-W., Rabadàn, R., McIntire, L. B. J., Gartrell, R. D., Kelly, J. M., Laiakis, E. C., & Vanpouille-Box, C. (2023). Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma. Cancer Letters, 570, 216329. https://doi.org/10.1016/j.canlet.2023.216329

Papachristodoulou, A., & Abate-Shen, C. (2022). Precision intervention for prostate cancer: Re-evaluating who is at risk. Cancer Letters, 538, 215709. https://doi.org/10.1016/j.canlet.2022.215709

Kanagasabai, T., Li, G., Shen, T. H., Gladoun, N., Castillo-Martin, M., Celada, S. I., Xie, Y., Brown, L. K., Mark, Z. A., Ochieng, J., Ballard, B. R., Cordon-Cardo, C., Adunyah, S. E., Jin, R., Matusik, R. J., & Chen, Z. (2022). MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway. Cancer Letters, 525, 46–54. https://doi.org/10.1016/j.canlet.2021.09.041